A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: Genomic structure and polymorphism screening in manic-depressive patients

Molecular Psychiatry

Volumn 5, Issue 2, 2000, Pages 172-180

  Sjoholt G ^a   Gulbrandsen, A K ^a   Lovlie R ^a   Berle, J O ^a   Molven, A ^a   Steen, V M ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bipolar disorder; Chromosome 18; DNA polymorphism; IMPA2; Inositol monophosphatase; Inositol signaling; Lithium

Indexed keywords

AMINO ACID; INOSITOL 1 PHOSPHATASE; LITHIUM; MYOINOSITOL MONOPHOSPHATASE; NUCLEOTIDE; PHOSPHATASE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 18P; CLINICAL ARTICLE; EXON; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HOUSEKEEPING GENE; HUMAN; INTRON; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 0000685667     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000681     Document Type: Article

References (29)

1. 1 Goodwin FK, Jamison KR. Manic-depressive Illness. Oxford University Press: New York, 1990.
2. 2 Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 1994; 164: 208-214.
3. 3 Maj M, Pirozzi R, Magliano L. Late non-response to lithium prophylaxis in bipolar patients: prevalence and predictors. J Affect Disord 1996; 39: 39-42.
4. 4 Vestergaard P, Wentzer LR, Brodersen A, Rasmussen NA, Christensen H, Arngrim T et al. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels. Acta Psychiatr Scand 1998; 98: 310-315.
5. 5 Manji HK, Potter WZ, Lenox RH. Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 1995; 52: 531-543.
6. 6 Lenox RH, McNamara RK, Papke RL, Manji HK. Neurobiology of lithium: an update. J Clin Psychiatry 1998; 59: 37-47.
7. 7 Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989; 59: 411-419.
8. 8 Allison JH, Blisner ME, Holland WH, Hipps PP, Sherman WR. Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem Biophys Res Commun 1976; 71: 664-670.
9. 9 Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982; 206: 587-595.
10. 10 Dixon JF, Lee CH, Los GV, Hokin LE. Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices. J Neurochem 1992; 59: 2332-2335.
11. 11 Kennedy ED, Challiss RA, Ragan CI, Nahorski SR. Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices. Biochem J 1990; 267: 781-786.
12. 12 del Rio E, Shinomura T, van der Kaay J, Nicholls DG, Downes CP. Disruption by lithium of phosphoinositide signalling in cerebellar granule cells in primary culture. J Neurochem 1998; 70: 1662-1669.
13. 13 Steen VM, Løvlie R, Osher Y, Belmaker RH, Berle JØ, Gulbrandsen AK. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 1998; 8: 259-268.
14. 14 Steen VM, Gulbrandsen AK, Eiken HG, Berle JØ. Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness. Pharmacogenetics 1996; 6: 113-116.
15. 15 Sjøholt G, Molven A, Løvlie R, Wilcox A, Sikela JM, Steen VM. Genomic structure and chromosomal localization of a human myoinositol monophosphatase gene (IMPA). Genomics 1997; 45: 113-122.
16. 16 Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD. A novel human myo-inositol monophosphatase gene, IMP.18p. maps to a susceptibility region for bipolar disorder. Mol Psychiatry 1997; 2: 393-397.
17. 17 York JD, Ponder JW, Majerus PW. Definition of a metaldependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci USA 1995; 92: 5149-5153.
18. 18 Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI et al. Chromosome 18 DNA markers and manicdepressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918-5921.
19. 19 Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
20. 20 Nöthen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry 1999; 4: 76-84.
21. 21 Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-5609.
22. 22 Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998; 63: 1139-1152.
23. 23 Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol Psychiatry 1998; 3: 481-482.
24. 24 Ausubel FM, Brent R, Kingston RE, Moore D, Seidman JG, Smith JA et al. Current Protocols in Molecular Biology. John Wiley and Sons: New York, 1995.
25. 25 Azizkhan JC, Jensen DE, Pierce AJ, Wade M. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit Rev Eukaryot Gene Expr 1993; 3: 229-254.
26. 20 Schuller HJ, Richter K, Hoffmann B, Ebbert R, Schweizer E. DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesis. FEBS Lett 1995; 370: 149-152.
27. 27 Van Dijken P, Bergsma JC, Hiemstra HS, De Vries B, Van Der Kaay J, Van Haastert PJ. Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium. Biochem J 1996; 314: 491-495.
28. 28 Gillaspy GE, Keddie JS, Oda K, Gruissem W. Plant inositol monophosphatase is a lithium-sensitive enzyme encoded by a multigene family. Plant Cell 1995; 7: 2175-2185.
29. 20 Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11: 1-3.